Department of Biotechnology hosts webinar on biomanufacturing of enzymes
The session focused on “Biomanufacturing of Enzymes,” a critical domain under the BioE3 Policy.
The session focused on “Biomanufacturing of Enzymes,” a critical domain under the BioE3 Policy.
WHO estimates suggest that 150 million people worldwide are affected by Trachoma
Professor G. D. Yadav is one of India’s most prolific and accomplished engineering-scientists, holding the prestigious National Science Chair from the Government of India
The award is for development of Nafithromycin, which is the first ever multi-drug resistant pathogen active respiratory antibiotic for the treatment of Community-Acquired Bacterial Pneumonia
India's bio economy has experienced remarkable growth, skyrocketing from US $10 billion in 2014 to over $130 billion in 2024, with projections to reach $300 billion by 2030
The BPaLM regimen, which consists four-drug combination – Bedaquiline, Pretomanid, Linezolid and Moxifloxacin, has been proven to be safe, more effective and a quicker treatment option than the previous MDR-TB treatment procedure
Stressed was on the need to promote organ donation from the deceased persons to meet the huge need for organ donation in the country
These digital initiatives are expected to enhance the accessibility and efficiency of drug safety monitoring and standards compliance
Subscribe To Our Newsletter & Stay Updated